Revolution Medicines · 19 hours ago
Intern, Biostatistics
San Francisco Bay Area
Internship
Hybrid
Intern
$67K/yr - $81K/yrRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies. The Biostatistics summer intern will work under the supervision of experienced Biostatisticians on problems related to clinical drug development research in Oncology, implementing methodological developments and conducting simulation studies.
Health CareLife ScienceMedical
Responsibilities
Work for 8-12 weeks under the supervision of experienced Biostatisticians on theoretical or applied problems with direct relevance to on-going clinical drug development research in Oncology
Implement new methodological developments using SAS/R and conduct simulation studies as needed
Give a department-wide presentation on their research topic and prepare a final written report
Qualification
Required
Must have strong programming skills in SAS or R
Must have a solid background on survival analysis
Demonstrated problem-solving ability and strong oral and written communication skills
Enrollment in a full-time graduate program and have completed at least two full years of graduate course work prior to the start of the internship
Preferred
Familiarity with advanced statistical methods including ML, causal inference, Bayesian statistics, external control and observational studies
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Founded in 2015
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase